论文部分内容阅读
摘要目的评价MRI对无可见脂肪的血管平滑肌脂肪瘤(AML_(wvf))的诊断价值。方法经伦理委员会核准,回顾性分析2002—2013年间行对比增强MRI检查(CE-MRI)发现的<4 cm肾脏实性肿块的全部病人。10例AMLwvf与77例肾细胞癌(RCC)比较,RCC包括33例透明细胞癌(cc-RCC)、35例乳头状肾细胞癌(p-RCC)、9例嫌色细胞肾癌(ch-
Abstract Objective To evaluate the diagnostic value of MRI in the diagnosis of the absence of visible fat in patients with angiomyolipoma (AML_ (wvf)). Methods Approved by the Ethics Committee, all patients with <4 cm neoplastic solid tumors found during contrast-enhanced MRI (CE-MRI) between 2002 and 2013 were retrospectively reviewed. There were 33 cases of clear cell carcinoma (cc-RCC), 35 cases of papillary renal cell carcinoma (p-RCC) and 9 cases of chromophobe renal cell carcinoma (RCC)